Serum IL-17A in Behcet's disease


Creative Commons License

Emiroglu N. , Cengiz F. P. , ERDEM G. B.

POSTEPY DERMATOLOGII I ALERGOLOGII, cilt.32, ss.358-361, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 32 Konu: 5
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5114/pdia.2015.54745
  • Dergi Adı: POSTEPY DERMATOLOGII I ALERGOLOGII
  • Sayfa Sayısı: ss.358-361

Özet

Introduction: Behcet's disease is a chronic multisystem disease with spontaneous remissions and relapses. Several studies show that autoimmune mechanisms play an important role in the development of Behcet's disease. Activation of T cells and neutrophils is important in the pathogenesis of the disease. Interleukin 17 (IL-17) is a new cytokine that induces several types of cells to secrete proinflammatory cytokines in many inflammatory and autoimmune diseases.